-+ 0.00%
-+ 0.00%
-+ 0.00%

Shanghai Bao Pharmaceuticals files HKEX next-day disclosure on share repurchase

PUBT·07/20/2026 10:35:12
Listen to the news
Shanghai Bao Pharmaceuticals files HKEX next-day disclosure on share repurchase
  • Shanghai Bao Pharmaceuticals repurchased 112,200 H shares on July 20, 2026 for treasury, with no shares bought back for cancellation.
  • Buyback price range HKD 17.18 to HKD 18.01; total consideration HKD 1.99 million.
  • Treasury shares rose to 1,260,800; issued shares excluding treasury fell to 153,066,450.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Bao Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260720-12249865), on July 20, 2026, and is solely responsible for the information contained therein.